CLINICAL_TRIALS
trial_result
· 2025-09-10
Clinical Trial Update: A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer [Phase 2]
Summary
Phase 2 clinical trial evaluating the addition of atorvastatin to endocrine therapy for advanced breast cancer; the study focuses on resistance mechanisms to Fu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lund University Hospital | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED